Literature DB >> 28167127

"With a little help from my friends" - The role of microbiota in thyroid hormone metabolism and enterohepatic recycling.

Camilla Virili1, Marco Centanni2.   

Abstract

The gut microbiota is composed of over 1200 species of anaerobes and aerobes bacteria along with bacteriophages, viruses and fungal species. Increasing evidence indicates that the intestinal microbiota, beside digestive equilibrium, is also crucial for immunologic, hormonal and metabolic homeostasis. The intestinal microbiota interacts with distant organs by signals which may be part of the bacteria themselves or their metabolites. Dysbiosis has been observed in inflammatory or autoimmune disorders such as multiple sclerosis or type 1 diabetes as well as in obesity and type 2 diabetes. Functional thyroid disorders were associated with bacterial overgrowth and a different microbial composition. Although thyroid metabolism was apparently disregarded, the interference of microbiota on peripheral iodothyronine homeostasis is an intriguing issue. In this review we focused on the interactions of intestinal microbiota with thyroid-related micronutrients and with the metabolic steps of endogenous and exogenous iodothyronines.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Enterohepatic circulation; Iodothyronines metabolism; Levothyroxine; Microbiota; Selenium; Thyroxine malabsorption

Mesh:

Substances:

Year:  2017        PMID: 28167127     DOI: 10.1016/j.mce.2017.01.053

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  29 in total

Review 1.  Novel thyroxine formulations: a further step toward precision medicine.

Authors:  Camilla Virili; Pierpaolo Trimboli; Marco Centanni
Journal:  Endocrine       Date:  2019-10-15       Impact factor: 3.633

2.  Dysbiosis of the gut microbiome is associated with thyroid cancer and thyroid nodules and correlated with clinical index of thyroid function.

Authors:  Jiaming Zhang; Fanghua Zhang; Changying Zhao; Qian Xu; Cheng Liang; Ying Yang; Huiling Wang; Yongfang Shang; Ye Wang; Xiaofeng Mu; Dequan Zhu; Chunling Zhang; Junjie Yang; Minxiu Yao; Lei Zhang
Journal:  Endocrine       Date:  2018-12-24       Impact factor: 3.633

3.  Levothyroxine Absorption Test to Differentiate Pseudomalabsorption from True Malabsorption.

Authors:  Sujoy Ghosh; Subhodip Pramanik; Kaushik Biswas; Kingshuk Bhattacharjee; Rajib Sarkar; Subhankar Chowdhury; Pradip Mukhopadhyay
Journal:  Eur Thyroid J       Date:  2019-11-20

Review 4.  Endocrine disruptors and gut microbiome interactions.

Authors:  R Hampl; L Stárka
Journal:  Physiol Res       Date:  2020-09-30       Impact factor: 1.881

5.  Levothyroxine treatment and gastric juice pH in humans: the proof of concept.

Authors:  Camilla Virili; Giovanni Bruno; Maria Giulia Santaguida; Lucilla Gargano; Ilaria Stramazzo; Corrado De Vito; Alessia Cicenia; Giulia Scalese; Barbara Porowska; Carola Severi; Marco Centanni
Journal:  Endocrine       Date:  2022-04-27       Impact factor: 3.925

Review 6.  Gut microbiota and Hashimoto's thyroiditis.

Authors:  Camilla Virili; Poupak Fallahi; Alessandro Antonelli; Salvatore Benvenga; Marco Centanni
Journal:  Rev Endocr Metab Disord       Date:  2018-12       Impact factor: 6.514

7.  Levothyroxine Therapy: Changes of TSH Levels by Switching Patients from Tablet to Liquid Formulation. A Systematic Review and Meta-Analysis.

Authors:  Camilla Virili; Luca Giovanella; Poupak Fallahi; Alessandro Antonelli; Maria Giulia Santaguida; Marco Centanni; Pierpaolo Trimboli
Journal:  Front Endocrinol (Lausanne)       Date:  2018-01-26       Impact factor: 5.555

Review 8.  Diagnosis and management of treatment-refractory hypothyroidism: an expert consensus report.

Authors:  M Centanni; S Benvenga; I Sachmechi
Journal:  J Endocrinol Invest       Date:  2017-07-10       Impact factor: 4.256

Review 9.  Torpor: The Rise and Fall of 3-Monoiodothyronamine from Brain to Gut-From Gut to Brain?

Authors:  Hartmut H Glossmann; Oliver M D Lutz
Journal:  Front Endocrinol (Lausanne)       Date:  2017-05-31       Impact factor: 5.555

10.  Thyroxine Treatment With Softgel Capsule Formulation: Usefulness in Hypothyroid Patients Without Malabsorption.

Authors:  Pierpaolo Trimboli; Camilla Virili; Marco Centanni; Luca Giovanella
Journal:  Front Endocrinol (Lausanne)       Date:  2018-03-21       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.